Identification of human gastric carcinoma biomarkers by differential protein expression analysis using 18O labeling and NanoLC-MS/MS coupled with laser capture microdissection

Medical Oncology

Volumn 27, Issue 2, 2010, Pages 296-303

  Zhang, ZhiQiang ^a,b   Li, MaoYu ^c   Zhang, GuiYing ^a   Pan, Fang ^c   Yao, HuiXing ^c   Xiao, ZhiQiang ^c   Chen, ZhuChu ^c  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b XINJIANG MEDICAL UNIVERSITY   (China)

^c CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

18O labeling; Gastric cancer; Laser capture microdissection; Quantitative proteomics; Tumor biomarkers

Indexed keywords

BIOLOGICAL MARKER; OXYGEN 18;

ARTICLE; CLINICAL ARTICLE; DOWN REGULATION; FEMALE; HUMAN; HUMAN TISSUE; ISOTOPE LABELING; LASER CAPTURE MICRODISSECTION; LIQUID CHROMATOGRAPHY; MALE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; STOMACH CARCINOMA; TANDEM MASS SPECTROMETRY; UPREGULATION; WESTERN BLOTTING;

AMINO ACID SEQUENCE; CHROMATOGRAPHY, LIQUID; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LASERS; MICRODISSECTION; MOLECULAR SEQUENCE DATA; NANOTECHNOLOGY; NEOPLASM PROTEINS; OXYGEN ISOTOPES; STOMACH NEOPLASMS; TANDEM MASS SPECTROMETRY; TUMOR MARKERS, BIOLOGICAL;

EID: 77956895169     PISSN: 13570560     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12032-009-9208-x     Document Type: Article

References (20)

1. Roder DM. The epidemiology of gastric cancer. Gastric Cancer. 2002;5(Suppl 1):5-11. doi:10.1007/s10120-002-0203-6. (Pubitemid 36604663)
2. Alberts SR, Cervantes A, van de Velde CJ. Gastric cancer: epidemiology, pathology and treatment. Ann Oncol. 2003; 14(Suppl 2):ii31-6.
3. Henning GT, Schild SE, Stafford SL, et al. Results of irradiation or chemo irradiation following resection of gastric adenocarcinoma. Int J Radiat Oncol Biol Phys. 2000;46(3):589-98. doi:10.1016/S0360-3016(99)00446-0. (Pubitemid 30100636)
4. Reymond MA, Schlegel W. Proteomics in cancer. Adv Clin Chem. 2007;44:103-42. doi:10.1016/S0065-2423(07)44004-5.
5. Bantscheff M, Schirle M, Sweetman G, et al. Quantitative mass spectrometry in proteomics: a critical review. Anal Bioanal Chem. 2007;389(4):1017-31. doi:10.1007/s00216-007-1486-6. (Pubitemid 47482251)
6. Sakai J, Kojima S, Yanagi K, Kanaoka M. 18O-labeling quantitative proteomics using an ion trap mass spectrometer. Proteomics. 2005;5(1):16-23. doi:10.1002/pmic.200300885. (Pubitemid 40189633)
7. Lassman ME, Rahbar A, Medintz IL, Ligler FS. Incorporation of (18)oxygen into peptide mixtures and analysis with multidimensional chromatography and mass-spectroscopy. Anal Lett. 2007;40(10):1864-78. doi:10.1080/ 00032710701384659. (Pubitemid 47300207)
8. Emmert-Buck MR, Bonner RF, Smith PD, et al. Laser capture microdissection. Science. 1996;274(5289):998-1001. doi:10.1126/ science.274.5289.998.
9. Craven RA, Banks RE. Laser capture microdissection and proteomics: possibilities and limitation. Proteomics. 2001;1(10): 1200-4. doi:10.1002/1615-9861(200110)1:10<1200::AID-PROT 1200>3.0.CO;2-Q.
10. Lane CS, Wang Y, Betts R, et al. Comparative cytochrome P450 proteomics in the livers of immunodeficient mice using 18O stable isotope labeling. Mol Cell Proteomics. 2007;6(6):953-62. doi:10.1074/mcp.M600296-MCP200. (Pubitemid 47019397)
11. Zeeberg BR, Feng W, Wang G, et al. GoMiner: a resource for biological interpretation of genomic and proteomic data. Genome Biol. 2003;4(4):R28. doi:10.1186/gb-2003-4-4-r28.
12. Zang L, Toy DP, Hancock WS, et al. Proteomic analysis of ductal carcinoma of the breast using laser capture microdissection, LCMS, and O-16/O-18 isotopic labeling. J Proteome Res. 2004;3(3):604-12. doi:10.1021/pr034131l. (Pubitemid 39207366)
13. Hood BL, Darfler MM, Guiel TG, et al. Proteomic analysis of formalin-fixed prostate cancer tissue. Mol Cell Proteomics. 2005;4(11):1741-53. doi:10.1074/mcp.M500102-MCP200. (Pubitemid 41749267)
14. Lopez-Ferrer D, Ramos-Fernandez A, Martinez-Bartolome S, et al. Quantitative proteomics using (16)O/(18)O labeling and linear ion trap mass spectrometry. Proteomics. 2006;6(Suppl 1):S4-11. doi:10.1002/pmic.200500375.
15. Miyagi M, Rao KC. Proteolytic 18O-labeling strategies for quantitative proteomics. Mass Spectrom Rev. 2007;26(1): 121-36. doi:10.1002/mas.20116. (Pubitemid 46061256)
16. Seow TK, Liang RC, Leow CK, Chung MC. Hepatocellular carcinoma: from bedside to proteomics. Proteomics. 2001; 1(10):1249-63. doi:10.1002/1615- 9861(200110)1:10<1249::AIDPROT1249> 3.0.CO;2-1.
17. Bantscheff M, Dumpelfeld B, Kuster B. Femtomol sensitivity post-digest (18)O labeling for relative quantification of differential protein complex composition. Rapid Commun Mass Spectrom. 2004;18(8):869-76. doi:10.1002/rcm. 1418.
18. Sun G, Anderson VE. A strategy for distinguishing modified peptides based on post-digestion 18O labeling and mass spectrometry. Rapid Commun Mass Spectrom. 2005;19(19):2849-56. doi:10.1002/rcm.2133. (Pubitemid 41383370)
19. Fu Z, Kitagawa Y, Shen R, et al. Metastasis suppressor gene Raf kinase inhibitor protein (RKIP) is a novel prognostic marker in prostate cancer. Prostate. 2006;66(3):248-56. doi:10.1002/pros. 20319.
20. Minoo P, Zlobec I, Baker K, et al. Loss of raf-1 kinase inhibitor protein expression is associated with tumor progression and metastasis in colorectal cancer. Am J Clin Pathol. 2007;127(5): 820-7. doi:10.1309/5D7MM22DAVGDT1R8.